US 8617557
Antibody fusion with IL-12 proteins with disrupted heparin-binding activity
granted A61PA61P35/00
Quick answer
US patent 8617557 (Antibody fusion with IL-12 proteins with disrupted heparin-binding activity) held by The Regents of the University of California expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00